https://www.thebodypro.com/category/hiv-treatment-strategies/tag/news-analysis

The Latest

doctor getting ready to give patient vaccine

HIV Vaccine Trial Stopped Early, but Research Into Other Approaches Continues

HVTN 702 is but one of many vaccine trials underway, researchers note.

woman from behind with arms crossed over head

Barriers to Cisgender Women and HIV Prevention

Health care providers and educators need to acknowledge the impact of clinical bias and reframe sexual health education when it comes to tending to cisgender women's needs, Chase Alston writes.

syringe going into vial

FDA Rejects Injectable HIV Treatment, but Not Due to Drug Safety

This may be a temporary setback, but long-acting antiretroviral therapy is still on the way, experts say.

Customer giving medical prescription to pharmacist

What Needs to Happen Before California Pharmacies Can Sell PrEP and PEP Without an Initial Prescription

Pharmacists will increasingly play a role in pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) access in California.

Washington DC at sunset, including Washington Monument

IDWeek 2019: What to Expect at This Year's Conference

We're covering the latest news and research from this major interdisciplinary meeting on infectious diseases, which takes place in Washington, D.C., from Oct. 2 to Oct. 6.

Mexico City's Downtown At Twilight

IAS 2019: What to Expect in HIV Science

Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare Img

Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare

Providers, payers, and health systems need to catch up, said Melanie Thompson, M.D., at the ACTHIV conference.

Long-Acting HIV Antiretrovirals May Be Revolutionary. But Will They Be Worth It? Img

Long-Acting HIV Antiretrovirals May Be Revolutionary. But Will They Be Worth It?

A single drug dose, taken no more than once a month, to treat HIV: It's no longer the stuff of idle fantasy. But in a world stuffed with excellent once-a-day drugs, will long-acting meds have value?

Promo Image

Discussion of Proposal for Free Access to NIH-Funded Research

The U.S. National Institutes of Health is seeking public comment on a proposal for "establishing a comprehensive, searchable resource of NIH-funded research results and providing free access for all" -- but with important limitations. The proposal, s...